Trial intelligence / Profile preview

Naltrexone for cannabis addiction

NL-OMON35633Recruiting

Sponsor
Centrum Maliebaan Bezoekadres: Tolsteegsingel 2a 3582 AC Utrecht Postadres: Postbus 14116 3508 SE Utrecht tel. algemeen: 030-234 00 34 fax: 030-233 29 80
Start
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of naltrexone in cannabis use disorder (CUD), sponsored by Centrum Maliebaan Bezoekadres: Tolsteegsingel 2a 3582 AC Utrecht Postadres: Postbus 14116 3508 SE Utrecht tel. algemeen: 030-234 00 34 fax: 030-233 29 80. Started Sep 2010; status: recruiting.

02

Drugs

naltrexone
03

Conditions

cannabis use disorder (CUD)

Beyond the preview

Go deeper on NL-OMON35633.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON35633.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call